Status:
UNKNOWN
Use of Hair to Diagnose Breast Cancer
Lead Sponsor:
Fermiscan Ltd
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
20+ years
Phase:
PHASE1
PHASE2
Brief Summary
Study FT3.6k-2006 is a single centre (the Mater Hospital, Sydney), blinded trial of a diagnostic test for breast cancer, with outcomes compared to the gold standard of screening mammogram followed by ...
Detailed Description
The test has the potential to improve the diagnostic (and consequently therapeutic) paradigm for breast cancer. Women attending a radiology clinic in the Mater Hospital, Sydney, for a mammogram will ...
Eligibility Criteria
Inclusion
- Adult women (aged \>20) who are undergoing mammography at the Mater Hospital, Sydney, and
- Who are willing and able to provide informed consent; and
- Who have usable scalp and/or pubic hair
Exclusion
- Women who have dyed or permed their scalp hair within the previous 6 weeks and whose pubic hair is unavailable;
- Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN \[cervical intra-epithelial neoplasia\]) within 5 years.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
3600 Patients enrolled
Trial Details
Trial ID
NCT00419679
Start Date
December 1 2006
Last Update
January 9 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Mater Hospital
Sydney, New South Wales, Australia, 2065